These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 27226497

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
    Chen HC, Chen YL, Guo BF, Tsai TH, Chang JP, Pan KL, Lin YS, Chen MC.
    Can J Cardiol; 2013 Sep; 29(9):1110-7. PubMed ID: 23474139
    [Abstract] [Full Text] [Related]

  • 3. Perioperative management of antithrombotic therapy in patients receiving cardiovascular implantable electronic devices: a network meta-analysis.
    He H, Ke BB, Li Y, Han FS, Li X, Zeng YJ.
    J Interv Card Electrophysiol; 2017 Oct; 50(1):65-83. PubMed ID: 28842832
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
    Jennings JM, Robichaux R, McElderry HT, Plumb VJ, Gunter A, Doppalapudi H, Osorio J, Yamada T, Kay GN.
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1125-9. PubMed ID: 23889767
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial.
    Essebag V, Healey JS, Ayala-Paredes F, Kalfon E, Coutu B, Nery P, Verma A, Sapp J, Philippon F, Sandhu RK, Coyle D, Eikelboom J, Wells G, Birnie DH.
    Am Heart J; 2016 Mar; 173():102-7. PubMed ID: 26920602
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical predictors of pocket hematoma after cardiac device implantation and replacement.
    Ferretto S, Mattesi G, Migliore F, Susana A, De Lazzari M, Iliceto S, Leoni L, Bertaglia E.
    J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):123-127. PubMed ID: 31789710
    [Abstract] [Full Text] [Related]

  • 11. Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices.
    Korantzopoulos P, Letsas KP, Liu T, Fragakis N, Efremidis M, Goudevenos JA.
    Europace; 2011 Dec; 13(12):1669-80. PubMed ID: 21788280
    [Abstract] [Full Text] [Related]

  • 12. Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?
    Beton O, Saricam E, Kaya H, Yucel H, Dogdu O, Turgut OO, Berkan O, Tandogan I, Yilmaz MB.
    BMC Cardiovasc Disord; 2016 Apr 22; 16():73. PubMed ID: 27105588
    [Abstract] [Full Text] [Related]

  • 13. Management of antithrombotic therapy in patients undergoing electrophysiological device surgery.
    Zacà V, Marcucci R, Parodi G, Limbruno U, Notarstefano P, Pieragnoli P, Di Cori A, Bongiorni MG, Casolo G.
    Europace; 2015 Jun 22; 17(6):840-54. PubMed ID: 25712980
    [Abstract] [Full Text] [Related]

  • 14. Rationale, study design, and pilot phase of tHE Management of AntiThrOMbotic therApy (HEMATOMA) in patients undergoing electrophysiological device surgery: Italian National Multicenter Observational REgistry.
    Zacà V, Breschi M, Mandorli A, Panchetti L, Ricciardi G, Viani S, Notarstefano P.
    J Cardiovasc Med (Hagerstown); 2017 Nov 22; 18(11):897-899. PubMed ID: 28594654
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Device implantation for patients on antiplatelets and anticoagulants: Use of suction drain.
    Mukherjee SS, Saggu D, Chennapragada S, Yalagudri S, Nair SG, CalamburNarasimhan.
    Indian Heart J; 2018 Dec 22; 70 Suppl 3(Suppl 3):S389-S393. PubMed ID: 30595295
    [Abstract] [Full Text] [Related]

  • 17. Pocket related complications following cardiac electronic device implantation in patients receiving anticoagulation and/or dual antiplatelet therapy: prospective evaluation of different preventive strategies.
    Awada H, Geller JC, Brunelli M, Ohlow MA.
    J Interv Card Electrophysiol; 2019 Apr 22; 54(3):247-255. PubMed ID: 30460588
    [Abstract] [Full Text] [Related]

  • 18. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R, Boveda S, Haugaa KH, Potpara TS, Syska P, Jedrzejczyk-Patej E, Chauvin M, Sadoul N, Dagres N.
    Europace; 2018 Jul 01; 20(7):1218-1224. PubMed ID: 29762683
    [Abstract] [Full Text] [Related]

  • 19. Interrupted versus uninterrupted novel oral anticoagulant peri-implantation of cardiac device: A single-center randomized prospective pilot trial.
    Ricciardi D, Creta A, Colaiori I, Scordino D, Ragni L, Picarelli F, Calabrese V, Providência R, Ioannou A, Di Sciascio G.
    Pacing Clin Electrophysiol; 2018 Nov 01; 41(11):1476-1480. PubMed ID: 30132926
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.